当前位置: 首页 > 医学版 > 教育就业 > 继续教育 > 血液科 > 06 > 正文
编号:10300394
http://www.100md.com 2003年9月26日 好医生
上一页1 2 3 4
     17. Jones RN. Clinical use of ?-lactamase inhibitors in combination with extended-spectrum penicillins. Am J Health Syst Pharm 1995; 52 Suppl. 2: 29-33

    18. Sanders WE, Sanders CC. Piperacillin/tazobactam: a critical review of the evolving clinical literature. Clin Infect Dis 1996; 22: 107-23

    19. Schoonover LL, occhipinti DJ, Rodvold KA, et al. Piperacillin/tazobactam: a new beta-Iactam/beta-Iactamase inhibitor combination. Ann Pharmacother 1995; 29; 501-13

    20.Huizinga WKJ. Piperacillin/tazobactam: New evidence fort he management of intra-abdominal infection. Presented at the 7th European Congress of Clinical Microbiology and Infectious Diseases, Vienna, Austria 1995. Abstract 573.

    21.汪复,朱德妹,张婴元。1998年上海地区细菌耐药性监测。中华内科杂志,1999,38:729

    22. C.pena, et al. AAC 42:53 1998

    23. L. Rice , et al. Clin Inf. Dis 23:118, 1996

    24. J.paterson et al. Inf. Cont. Hosp Epi 21; 455,2000

    25. Urban, etal. AAC 1994; 38:392-5 (李东华)